← 產業報告目錄
Companion Animal Pharmaceutical Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 124報告編號 APO-2038e8db23
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Companion Animal Pharmaceutical market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Companion Animal Pharmaceutical market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Companion Animal Pharmaceutical market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Companion Animal Pharmaceutical market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Companion Animal Pharmaceutical include Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Meiji, Ouro Fino Saude, Parnell, Vetoquinol and Virbac, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Companion Animal Pharmaceutical market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Companion Animal Pharmaceutical.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Companion Animal Pharmaceutical Market by Company
Boehringer Ingelheim
Ceva
Dechra Veterinary Products
Elanco Animal Health
Meiji
Ouro Fino Saude
Parnell
Vetoquinol
Virbac
Zoetis
Bayer Animal Health
Merck Animal Health
Companion Animal Pharmaceutical Segment by Type
Infectious Diseases
Orthopedic Diseases
Dermatologic Diseases
Pain
Behavioral Diseases
Other Indications
Companion Animal Pharmaceutical Segment by Application
Dogs
Cats
Other
Companion Animal Pharmaceutical Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Pharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Companion Animal Pharmaceutical companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Companion Animal Pharmaceutical by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Infectious Diseases
2.2.3 Orthopedic Diseases
2.2.4 Dermatologic Diseases
2.2.5 Pain
2.2.6 Behavioral Diseases
2.2.7 Other Indications
2.3 Companion Animal Pharmaceutical by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Dogs
2.3.3 Cats
2.3.4 Other
2.4 Assumptions and Limitations
3 Companion Animal Pharmaceutical Breakdown Data by Type
3.1 Global Companion Animal Pharmaceutical Historic Market Size by Type (2021-2026)
3.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Type (2027-2032)
4 Companion Animal Pharmaceutical Breakdown Data by Application
4.1 Global Companion Animal Pharmaceutical Historic Market Size by Application (2021-2026)
4.2 Global Companion Animal Pharmaceutical Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global Companion Animal Pharmaceutical Market Perspective (2021-2032)
5.2 Global Companion Animal Pharmaceutical Growth Trends by Region
5.2.1 Global Companion Animal Pharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Companion Animal Pharmaceutical Historic Market Size by Region (2021-2026)
5.2.3 Companion Animal Pharmaceutical Forecasted Market Size by Region (2027-2032)
5.3 Companion Animal Pharmaceutical Market Dynamics
5.3.1 Companion Animal Pharmaceutical Industry Trends
5.3.2 Companion Animal Pharmaceutical Market Drivers
5.3.3 Companion Animal Pharmaceutical Market Challenges
5.3.4 Companion Animal Pharmaceutical Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Companion Animal Pharmaceutical Players by Revenue
6.1.1 Global Top Companion Animal Pharmaceutical Players by Revenue (2021-2026)
6.1.2 Global Companion Animal Pharmaceutical Revenue Market Share by Players (2021-2026)
6.2 Global Companion Animal Pharmaceutical Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Companion Animal Pharmaceutical Head Office and Area Served
6.4 Global Companion Animal Pharmaceutical Players, Product Type & Application
6.5 Global Companion Animal Pharmaceutical Manufacturers Established Date
6.6 Global Companion Animal Pharmaceutical Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Companion Animal Pharmaceutical Market Size (2021-2032)
7.2 North America Companion Animal Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Companion Animal Pharmaceutical Market Size by Country (2021-2026)
7.4 North America Companion Animal Pharmaceutical Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Companion Animal Pharmaceutical Market Size (2021-2032)
8.2 Europe Companion Animal Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Companion Animal Pharmaceutical Market Size by Country (2021-2026)
8.4 Europe Companion Animal Pharmaceutical Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Companion Animal Pharmaceutical Market Size (2021-2032)
9.2 Asia-Pacific Companion Animal Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Companion Animal Pharmaceutical Market Size by Country (2021-2026)
9.4 Asia-Pacific Companion Animal Pharmaceutical Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Companion Animal Pharmaceutical Market Size (2021-2032)
10.2 South America Companion Animal Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Companion Animal Pharmaceutical Market Size by Country (2021-2026)
10.4 South America Companion Animal Pharmaceutical Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Companion Animal Pharmaceutical Market Size (2021-2032)
11.2 Middle East & Africa Companion Animal Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2021-2026)
11.4 Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Company Information
12.1.2 Boehringer Ingelheim Business Overview
12.1.3 Boehringer Ingelheim Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.1.4 Boehringer Ingelheim Companion Animal Pharmaceutical Product Portfolio
12.1.5 Boehringer Ingelheim Recent Developments
12.2 Ceva
12.2.1 Ceva Company Information
12.2.2 Ceva Business Overview
12.2.3 Ceva Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.2.4 Ceva Companion Animal Pharmaceutical Product Portfolio
12.2.5 Ceva Recent Developments
12.3 Dechra Veterinary Products
12.3.1 Dechra Veterinary Products Company Information
12.3.2 Dechra Veterinary Products Business Overview
12.3.3 Dechra Veterinary Products Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.3.4 Dechra Veterinary Products Companion Animal Pharmaceutical Product Portfolio
12.3.5 Dechra Veterinary Products Recent Developments
12.4 Elanco Animal Health
12.4.1 Elanco Animal Health Company Information
12.4.2 Elanco Animal Health Business Overview
12.4.3 Elanco Animal Health Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.4.4 Elanco Animal Health Companion Animal Pharmaceutical Product Portfolio
12.4.5 Elanco Animal Health Recent Developments
12.5 Meiji
12.5.1 Meiji Company Information
12.5.2 Meiji Business Overview
12.5.3 Meiji Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.5.4 Meiji Companion Animal Pharmaceutical Product Portfolio
12.5.5 Meiji Recent Developments
12.6 Ouro Fino Saude
12.6.1 Ouro Fino Saude Company Information
12.6.2 Ouro Fino Saude Business Overview
12.6.3 Ouro Fino Saude Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.6.4 Ouro Fino Saude Companion Animal Pharmaceutical Product Portfolio
12.6.5 Ouro Fino Saude Recent Developments
12.7 Parnell
12.7.1 Parnell Company Information
12.7.2 Parnell Business Overview
12.7.3 Parnell Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.7.4 Parnell Companion Animal Pharmaceutical Product Portfolio
12.7.5 Parnell Recent Developments
12.8 Vetoquinol
12.8.1 Vetoquinol Company Information
12.8.2 Vetoquinol Business Overview
12.8.3 Vetoquinol Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.8.4 Vetoquinol Companion Animal Pharmaceutical Product Portfolio
12.8.5 Vetoquinol Recent Developments
12.9 Virbac
12.9.1 Virbac Company Information
12.9.2 Virbac Business Overview
12.9.3 Virbac Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.9.4 Virbac Companion Animal Pharmaceutical Product Portfolio
12.9.5 Virbac Recent Developments
12.10 Zoetis
12.10.1 Zoetis Company Information
12.10.2 Zoetis Business Overview
12.10.3 Zoetis Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.10.4 Zoetis Companion Animal Pharmaceutical Product Portfolio
12.10.5 Zoetis Recent Developments
12.11 Bayer Animal Health
12.11.1 Bayer Animal Health Company Information
12.11.2 Bayer Animal Health Business Overview
12.11.3 Bayer Animal Health Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.11.4 Bayer Animal Health Companion Animal Pharmaceutical Product Portfolio
12.11.5 Bayer Animal Health Recent Developments
12.12 Merck Animal Health
12.12.1 Merck Animal Health Company Information
12.12.2 Merck Animal Health Business Overview
12.12.3 Merck Animal Health Revenue in Companion Animal Pharmaceutical Business (2021-2026)
12.12.4 Merck Animal Health Companion Animal Pharmaceutical Product Portfolio
12.12.5 Merck Animal Health Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Companion Animal Pharmaceutical Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Companion Animal Pharmaceutical Revenue Market Share by Type (2021-2026)
Table 7. Global Companion Animal Pharmaceutical Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Companion Animal Pharmaceutical Revenue Market Share by Type (2027-2032)
Table 9. Global Companion Animal Pharmaceutical Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Companion Animal Pharmaceutical Revenue Market Share by Application (2021-2026)
Table 11. Global Companion Animal Pharmaceutical Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Companion Animal Pharmaceutical Revenue Market Share by Application (2027-2032)
Table 13. Global Companion Animal Pharmaceutical Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Companion Animal Pharmaceutical Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Companion Animal Pharmaceutical Market Share by Region (2021-2026)
Table 16. Global Companion Animal Pharmaceutical Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Companion Animal Pharmaceutical Market Share by Region (2027-2032)
Table 18. Companion Animal Pharmaceutical Industry Trends
Table 19. Companion Animal Pharmaceutical Industry Drivers
Table 20. Companion Animal Pharmaceutical Industry Opportunities and Challenges
Table 21. Companion Animal Pharmaceutical Market Restraints
Table 22. Global Top Companion Animal Pharmaceutical Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Companion Animal Pharmaceutical Revenue Market Share by Players (2021-2026)
Table 24. Global Companion Animal Pharmaceutical Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Companion Animal Pharmaceutical, Headquarters and Area Served
Table 26. Global Companion Animal Pharmaceutical Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Companion Animal Pharmaceutical by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Companion Animal Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Companion Animal Pharmaceutical Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Companion Animal Pharmaceutical Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Companion Animal Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Companion Animal Pharmaceutical Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Companion Animal Pharmaceutical Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Companion Animal Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Companion Animal Pharmaceutical Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Companion Animal Pharmaceutical Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Companion Animal Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Companion Animal Pharmaceutical Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Companion Animal Pharmaceutical Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Companion Animal Pharmaceutical Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Companion Animal Pharmaceutical Market Size by Country (2027-2032) & (US$ Million)
Table 45. Boehringer Ingelheim Company Information
Table 46. Boehringer Ingelheim Business Overview
Table 47. Boehringer Ingelheim Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 48. Boehringer Ingelheim Companion Animal Pharmaceutical Product Portfolio
Table 49. Boehringer Ingelheim Recent Developments
Table 50. Ceva Company Information
Table 51. Ceva Business Overview
Table 52. Ceva Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 53. Ceva Companion Animal Pharmaceutical Product Portfolio
Table 54. Ceva Recent Developments
Table 55. Dechra Veterinary Products Company Information
Table 56. Dechra Veterinary Products Business Overview
Table 57. Dechra Veterinary Products Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 58. Dechra Veterinary Products Companion Animal Pharmaceutical Product Portfolio
Table 59. Dechra Veterinary Products Recent Developments
Table 60. Elanco Animal Health Company Information
Table 61. Elanco Animal Health Business Overview
Table 62. Elanco Animal Health Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 63. Elanco Animal Health Companion Animal Pharmaceutical Product Portfolio
Table 64. Elanco Animal Health Recent Developments
Table 65. Meiji Company Information
Table 66. Meiji Business Overview
Table 67. Meiji Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 68. Meiji Companion Animal Pharmaceutical Product Portfolio
Table 69. Meiji Recent Developments
Table 70. Ouro Fino Saude Company Information
Table 71. Ouro Fino Saude Business Overview
Table 72. Ouro Fino Saude Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 73. Ouro Fino Saude Companion Animal Pharmaceutical Product Portfolio
Table 74. Ouro Fino Saude Recent Developments
Table 75. Parnell Company Information
Table 76. Parnell Business Overview
Table 77. Parnell Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 78. Parnell Companion Animal Pharmaceutical Product Portfolio
Table 79. Parnell Recent Developments
Table 80. Vetoquinol Company Information
Table 81. Vetoquinol Business Overview
Table 82. Vetoquinol Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 83. Vetoquinol Companion Animal Pharmaceutical Product Portfolio
Table 84. Vetoquinol Recent Developments
Table 85. Virbac Company Information
Table 86. Virbac Business Overview
Table 87. Virbac Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 88. Virbac Companion Animal Pharmaceutical Product Portfolio
Table 89. Virbac Recent Developments
Table 90. Zoetis Company Information
Table 91. Zoetis Business Overview
Table 92. Zoetis Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 93. Zoetis Companion Animal Pharmaceutical Product Portfolio
Table 94. Zoetis Recent Developments
Table 95. Bayer Animal Health Company Information
Table 96. Bayer Animal Health Business Overview
Table 97. Bayer Animal Health Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 98. Bayer Animal Health Companion Animal Pharmaceutical Product Portfolio
Table 99. Bayer Animal Health Recent Developments
Table 100. Merck Animal Health Company Information
Table 101. Merck Animal Health Business Overview
Table 102. Merck Animal Health Revenue in Companion Animal Pharmaceutical Business (2021-2026) & (US$ Million)
Table 103. Merck Animal Health Companion Animal Pharmaceutical Product Portfolio
Table 104. Merck Animal Health Recent Developments
Table 105. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Companion Animal Pharmaceutical Product Image
Figure 5. Global Companion Animal Pharmaceutical Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Companion Animal Pharmaceutical Market Share by Type: 2025 VS 2032
Figure 7. Infectious Diseases Product
Figure 8. Orthopedic Diseases Product
Figure 9. Dermatologic Diseases Product
Figure 10. Pain Product
Figure 11. Behavioral Diseases Product
Figure 12. Other Indications Product
Figure 13. Global Companion Animal Pharmaceutical Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 14. Global Companion Animal Pharmaceutical Market Share by Application: 2025 VS 2032
Figure 15. Dogs Product
Figure 16. Cats Product
Figure 17. Other Product
Figure 18. Global Companion Animal Pharmaceutical Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 19. Global Companion Animal Pharmaceutical Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 20. Global Companion Animal Pharmaceutical Market Share by Region: 2025 VS 2032
Figure 21. Global Companion Animal Pharmaceutical Market Share by Players in 2025
Figure 22. Global Companion Animal Pharmaceutical Manufacturers Established Date
Figure 23. Global Top 5 and 10 Companion Animal Pharmaceutical Players Market Share by Revenue in 2025
Figure 24. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 25. North America Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. North America Companion Animal Pharmaceutical Market Share by Country (2021-2032)
Figure 27. United States Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Canada Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Mexico Companion Animal Pharmaceutical Market Share by Country (2021-2032)
Figure 30. Europe Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Europe Companion Animal Pharmaceutical Market Share by Country (2021-2032)
Figure 32. Germany Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. France Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. U.K. Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Italy Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Spain Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Russia Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Netherlands Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Nordic Countries Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Asia-Pacific Companion Animal Pharmaceutical Market Share by Country (2021-2032)
Figure 42. China Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. Japan Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. South Korea Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. India Companion Animal Pharmaceutical Market Share by Country (2021-2032)
Figure 47. Australia Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. China Taiwan Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. South America Companion Animal Pharmaceutical Market Share by Country (2021-2032)
Figure 52. Brazil Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Argentina Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Chile Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Colombia Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Peru Companion Animal Pharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
Figure 58. Ceva Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
Figure 59. Dechra Veterinary Products Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
Figure 60. Elanco Animal Health Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
Figure 61. Meiji Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
Figure 62. Ouro Fino Saude Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
Figure 63. Parnell Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
Figure 64. Vetoquinol Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
Figure 65. Virbac Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
Figure 66. Zoetis Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
Figure 67. Bayer Animal Health Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
Figure 68. Merck Animal Health Revenue Growth Rate in Companion Animal Pharmaceutical Business (2021-2026)
提及公司
Boehringer IngelheimCevaDechra Veterinary ProductsElanco Animal HealthMeijiOuro Fino SaudeParnellVetoquinolVirbacZoetisBayer Animal HealthMerck Animal Health
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們